Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial.

Although differences in the incidences of PNF and PGD between L-carnitine and placebo groups did not reach statistical significance, the rate of PNF occurrence in L-carnitine group was one-fourth of that in the placebo group and the incidence of PGD in L-carnitine group was approximately one-half of that in the placebo group.

also in 111,027 other papers